Laura Wingate: Biosimilars Can Improve Access to Treatment for Patients

Biosimilars can improve access to treatment for patients who might not have been able to access biologics previously, explained Laura Wingate, executive vice president, Education, Support, & Advocacy, Crohn's & Colitis Foundation.

Related Keywords

United States ,Laura Wingate ,Crohn Colitis Foundation ,Biosimilars ,Access ,Cost ,